BioLineRx Ltd.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
24.91 |
2.58 |
7.27 |
11.30 |
13.70 |
18.49 |
| Przychód Δ r/r |
0.00% |
-89.63% |
181.54% |
55.29% |
21.24% |
35.03% |
| Przychód (min) |
24.21 |
1.29 |
6.86 |
8.46 |
10.26 |
13.86 |
| Przychód (max) |
25.60 |
3.88 |
7.69 |
13.96 |
16.92 |
22.85 |
| EBITDA (średnia) |
10.64 |
1.10 |
3.11 |
4.82 |
5.85 |
7.90 |
| EBIT (średnia) |
9.94 |
1.03 |
2.90 |
4.51 |
5.46 |
7.38 |
| EBIT % |
39.90% |
39.90% |
39.90% |
39.90% |
39.90% |
39.90% |
| Zysk netto (średni) |
-235.73 |
-15.44 |
-20.37 |
-21.57 |
-39.14 |
-24.76 |
| Zysk netto % |
-946.25% |
-597.68% |
-280.01% |
-190.92% |
-285.78% |
-133.89% |
| EPS (średnia) |
-2.95 |
-0.19 |
-0.26 |
-0.27 |
-0.49 |
-0.31 |
| Liczba analityków (Przychody) |
2 |
2 |
2 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
2 |
1 |
1 |
1 |
1 |
| symbol |
BLRX |
BLRX |
BLRX |
BLRX |
BLRX |
BLRX |